Patent 7740869 was granted and assigned to Absynth Biologics on June, 2010 by the United States Patent and Trademark Office.
The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.